Company Profile
Affimed Stock Price, News & Analysis
- Ticker:
- AFMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Germany
Why the stock is moving
Current closing-price context is not available for AFMD.
Company overview
Business overview
Affimed was an immuno-oncology company focused on innate immunity and cell engager biology before its restructuring and public-market decline. Its platform aimed to activate the immune system against cancer.
Geographic Base and Sector Classification
Headquartered in Germany and listed on NASDAQ as an ADR before restructuring, Affimed sat in oncology biotechnology.
Business Model Characteristics
The business depended on clinical data, platform validation, and strategic financing to keep the pipeline moving.
Position Within the Biotechnology Landscape
Affimed belongs to the historical oncology-biotech set rather than the current live public-company universe.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Affimed do?
Affimed was an immuno-oncology company focused on innate immunity and cell engager biology before its restructuring and public-market decline. Its platform aimed to activate the immune system against cancer.
On which exchange is AFMD stock listed?
Affimed (AFMD) is associated with NASDAQ, Germany, Biopharma.
What is Affimed?
Affimed was an immuno-oncology company focused on innate immunity and cell engager biology before its restructuring and public-market decline.
Which conditions is Affimed targeting with Affimed?
Affimed is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.